Outsourced Pharma’s final program in 2016 was recently concluded in San Francisco. For the first time, technology companies, venture capital firms and others from Silicon Valley and elsewhere were invited to join the Outsourced Pharma community to focus on the topic of “Drug Development and Manufacturing Outsourcing in an Era of Technology.”
The focus of the agenda was to create a forum for open discussion on innovation and technology in outsourcing. In addition to those from pharma and biotech, technology and other industry thought-leaders were also invited to explore how relationships could be advanced and expand the parameters of partnerships as it relates to innovation in the external supply chain.
Louis Garguilo, Outsourced Pharma Event Chair and Chief Editor of OutsourcedPharma.com, said: “Over the past three years, we’ve continued to improve upon our model of open discussion and debate to uncover challenges facing – and between – the drug sponsors and owners and the contract development and manufacturing organizations. We look forward to building on this platform in 2017, and invite any professional in the industry involved with outsourcing or an external supply chain to join us.”
The conference included executives from companies such as Amgen, Achaogen and Pfizer. Throughout the two days, they and many others who are involved in outsourcing decisions at their companies discussed ideas on new models for further progress.
“It was extremely interesting hearing the speakers, panelists and even most importantly, the audience. Keep on pioneering, asking new questions and driving shifts in our healthcare system. We need it,” said Sheila Babnis, Innovator In Residence, Advisory Board, Launch Pad Central.
In addition to sponsoring speakers on the panel, the Outsourced Pharma Conference and Exhibition hosted 58 sponsors, providing industry attendees solutions to their outsourcing needs.
Outsourced Pharma is entering its fourth year of hosting biotechnology and pharmaceutical companies, contract development and manufacturing organizations (CDMOs/CMOs) and other outsourcing and supply-chain professionals. These thought-leadership conferences and exhibitions provide discussions of best practices and practical application of outsourcing skills, with an open format for panel and audience discussion.
About Outsourced Pharma Conference and Exhibition
Outsourced Pharma Conference & Exhibition is a vibrant forum for thought-leadership and the application of best practices for professionals engaged in outsourcing drug development and manufacturing. These conferences and exhibitions form a community for networking and discussing topics most relevant to sponsor-provider partnerships and supply-chain management, within an open format that promotes panel and attendee interaction.
About Outsourced Pharma
Outsourced Pharma provides comprehensive analysis of global outsourcing, the biotechnology and pharmaceutical industries, and their intersection with the overall life sciences and healthcare markets. We offer readers a deeper exploration and understanding of the relationships between service providers and their bio and pharma sponsors.
About Life Science Connect
Life Science Connect’s vision is to facilitate connections and foster collaborations in pharmaceutical, biotech, and medical device industries. We facilitate engagement across the drug development life cycle through our web portals, publications, events, and training.
SOURCE: Outsourced Pharma